Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Molecular basis of disease > Introduction to Lymphoma and Myeloma > Flashcards

Introduction to Lymphoma and Myeloma Flashcards

1
Q

Lymphoma

A

group of heterogenous cancers of mature lymphocytes that develop in lymph organs (B & T cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cause of lymphoma

A

Not clear, but many known to be due to specific gene mutations and chromosomal translocations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Main functions of the lymphatic system

A

· blood filtration/purification
· removal of excess fluids from tissues
· absorption and transport of lipids
· immune system activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lymph nodes

A

small lymph organs carrying out the functions of the lymphatic system
-located throughout the entire body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Types of lymph organs

A

Primary lymph organs

  • sites where stem cells can divide and become immunocompetent
  • thymus & bone marrow

Secondary lymph organs

  • sites where most of the immune responses occur
  • lymph nodes, spleen, appendix, Peyer’s patches, tonsil & adenoids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Effect of lymphoma (uncontrolled division of B & T cells)

A

Growth of certain lymph organs

  • e.g. lymph nodes (adenopathy)
  • e.g. spleen (splenomegaly)

Cancer cells spread to other tissues through lymphatic system

Might infiltrate in bone marrow (detectable in blood) and/or other organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clinical significance if lymphoma spreads to bone marrow

A

If it spreads to bone marrow, it can be deceiving and make us think it is leukaemia, when really it is a type of bone marrow infiltration of lymphoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Classification of Lymphoma

A

Traditional classification of lymphoma includes:
· Non-Hodgkin’s Lymphoma
· Hodgkin’s Lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prevalence of Hodgkin’s lymphoma

A

Hodgkin’s lymphoma is not very prevalent. It is not even among the 20 most common cancers in the UK and represent <1% of new cancer cases each year. Hodgkin’s lymphoma has two different peaks of incidence:

  • At adolescence
  • Males over 50
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Prevalence of Non-Hodgkin’s lymphoma

A

Non-Hodgkin’s lymphoma is more prevalent is tightly associated with age. It is more prevalent at older ages and is the 6th most common cancer in the UK.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Presentation of Lymphoma

A

Warning signs of lymphoma:

  • Fever
  • Swelling of face and neck
  • Lump in your neck, armpits or groin
  • Excessive sweating at night
  • Itchiness
  • Unexpected loss of weight
  • Loss of appetite
  • Breathlessness
  • Feeling of weakness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnosis of Lymphoma

A

· Lymph Node Biopsy

  • analyse microscopic sample
  • then immunophenotyping done including by flow cytometry, FISH and NGS

· PET Scans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Interpretation of PET Lymphoma Scans

A

PET Scans show how much the lymphoma has spread and therefore give us an idea of what stage the lymphoma is.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aetiology of lymphoma

A

Lymphoma is a multifactorial disorder (causes are not well known):

  • Malfunctioning of the body’s immune system
  • Exposure to certain infections (e.g. Epstein Barr Virus)

The triggers are unknown but most of lymphomas occur when a B cell develops/acquires a mutation in its DNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Hodgkin’s lymphoma?

How does Hodgkin’s lymphoma present?

A

clonal B-cell malignancy

non-painful enlarged lymph node(s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk factors of Hodgkin’s Lymphoma

A

~50% of cases due to Epstein-Barr Virus (EBV)

Family history

HIV/AIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Diagnosis of Hodgkin’s lymphoma

A

Excisional lymph node biopsy

> Reed-Sternberg cell under microscope (abnormal B lymphocytes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Characteristics of Reed-Sternberg cell

A
  • Bi-lobal nucleus
  • Enormous
  • Seen in a sea of normal B lymphocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Treatment of Hodgkin’s Lymphoma

A
  • Chemotherapy +/- radiation

- Stem cell transplant

20
Q

Prognosis of Hodgkin’s Lymphoma

A

5-year survival ~50-90% depending on age, stage and histology
-good results in young adults (97%)

21
Q

What is Non-Hodgkin’s Lymphoma?

A

complex group of blood cancers that include all types of lymphomas except the Hodgkin lymphomas

can be subdivided into grades:

  • high grade
  • low grade
  • high and low grade
22
Q

How does Non-Hodgkin lymphoma present?

A

enlarged lymph node(s)

  • some forms are slow and others are faster
  • general lymphoma symptoms
23
Q

Causes of Non-Hodgkin Lymphoma

A

Chromosome Translocations

24
Q

Risk factors of Non-Hodgkin Lymphoma

A

Virus Infections:

-e.g. EBV (HHv4) in Burkitt’s lymphomas in immunosuppressed patients

-e.g. Human T-cell leukaemia
virus in adult T-cell lymphoma

25
Q

How does EBV (HHV4) cause Non-Hodgkin’s lymphoma?

A

> directly transforms B-lymphocytes in culture due to viral oncogene LMP-1

> over half of all normal individuals carry latent EBV infection, but they do not develop lymphomas due to effective immune surveillance by cytotoxic T-cells

> HOWEVER, in highly immunosuppressed individuals (e.g. following organ transplant or HIV) the endogenous latent EBV may transform B-cells which are no longer eliminated by cytotoxic T-cells

> Develop high grade lymphoma

26
Q

Prognosis of Non-Hodgkin Lymphoma

A

overall 5-year survival rate ~70%

27
Q

Immunoglobulin expression in B-cells

A

· Ig genes are highly expressed in B-cells.

· Each Ig gene has a powerful tissue specific enhancer which enhances the expression of the Ig gene by activating the promoter of the rearranged V segment

*many lymphomas carry chromosome translocations involving the Ig heavy chain or light chain loci (chromosome 14).

28
Q

Follicular lymphoma (Non-Hodgkin’s)

A

t(14;18)(q32;q21)

  • this translocation brings together the BCL-2 gene (chr18) and the enhancer of the immunoglobulin (chr14)
  • enhancer will regulate the promoter of the BCL-2 gene, which is an apoptosis inhibitor
  • upregulation of this gene causes increased apoptosis inhibition, and cells will therefore survive and give rise to lymphoma
29
Q

Burkitt’s lymphoma (Non-Hodgkin’s)

A

t(8;14)(q24;32)= common translocation
>C-myc proto-oncogene (chr 8) and Ig gene (chr 14) are brought together
>enhancer of the Ig will regulate the promoter of the C-myc
>enhancer upregulates expression of C-myc, promoting cell proliferation and lymphoma

30
Q

Classifications of Non-Hodgkin’s lymphoma

A

Low Grade:
· Normal tissue architecture partially preserved-normal cell of origin recognisable
· Divide slowly
· May be present for many months before diagnosis
· Behave in an indolent fashion

High Grade:
· Loss of normal tissue architecture-normal cell of origin hard to determine
· Divide rapidly
· Present for a matter of weeks before diagnosis

· May be life-threatening

31
Q

Diagnosis of Non-Hodgkin’s lymphoma

A

Immunophenotyping

Cytogenetics- FISH (for chromosomal translocations)

Light chain restriction

PCR (to detect clonal Ig gene rearrangement)

32
Q

Treatment for Non-Hodgkin’s lymphoma

A
  • Chemotherapy
  • Radiotherapy
  • Stem cell transplant
  • Monoclonal Ab therapy- Rituximab (anti-CD20)
33
Q

Mechanism of action of Rituximab

A

Monoclonal antibody against CD20
-Rituximab binds all the CD20 molecules present on the cell surface of abnormal B-cells. As a consequence, immune system will recognise them and kill the abnormal B-cells.

34
Q

Myeloma

A

tumour of the bone marrow

antibodies produced by plasma cells are abnormal

-plasma cells synthesise a single monoclonal antibody called paraprotein (M component)

35
Q

Myeloma cells

A

abnormal plasma cells

36
Q

Presentation of myeloma

A

Initially: asymptomatic

Later: bone pain, bleeding, frequent infections and anaemia

37
Q

Cause of myeloma

A

unknown

38
Q

Risk factors of myeloma

A

Obesity
Radiation exposure
Family history
Certain chemicals

39
Q

Aspects of myeloma which give rise to clinical features

A

1) Suppression of normal bone marrow
2) Bone marrow resorption and calcium release
3) Pathological effects of paraprotein

40
Q

Bone marrow resorption and calcium release in myeloma

A

a) Myeloma cells produce cytokines (esp. IL-6) which will activate bone marrow stromal cells to release another cytokine RANKL→ osteoclast activation (lytic lesions of bone, bone pain, fractures)
b) Calcium released from bone causes hypercalcaemia (multiple symptoms including mental disturbance)

41
Q

Suppression of normal bone marrow in myeloma causes…

A

Anaemia
Recurrent infections
Bleeding tendency

42
Q

Pathological effects of paraprotein in myeloma

A

Paraprotein

  • precipitates in kidney tubules, causing renal failure
  • deposited as amyloid in many tissues
  • 2% of cases develop hyperviscosity syndrome → stroke & heart attack
43
Q

Diagnosis of myeloma

A

· Serum electrophoresis for paraprotein (𝛾 Ig)
· Urine electrophoresis for paraprotein (𝛾 Ig)
· Bone marrow biopsy for increased levels of plasma cells
· Erythrocyte sedmentation rate (ESR)- high due to stacking of the RBCs
· Flow cytometry and cytogenetic to detect cause
· Radiological investigation of skeleton for lytic lesions

44
Q

Treatment of myeloma

A

· Radiotherapy
· Chemotherapy
· Allogenic haematopoietic transplantation (ASCT) in young patients

45
Q

Prognosis of myeloma

A

Chemo + ASCT

-overall 5-year survival rate ~35%

Molecular basis of disease (31 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions